Exploiting the Campylobacter jejuni protein glycosylation system for glycoengineering vaccines and diagnostic tools directed against brucellosis
- PMID: 22276812
- PMCID: PMC3298491
- DOI: 10.1186/1475-2859-11-13
Exploiting the Campylobacter jejuni protein glycosylation system for glycoengineering vaccines and diagnostic tools directed against brucellosis
Abstract
Background: Immune responses directed towards surface polysaccharides conjugated to proteins are effective in preventing colonization and infection of bacterial pathogens. Presently, the production of these conjugate vaccines requires intricate synthetic chemistry for obtaining, activating, and attaching the polysaccharides to protein carriers. Glycoproteins generated by engineering bacterial glycosylation machineries have been proposed to be a viable alternative to traditional conjugation methods.
Results: In this work we expressed the C. jejuni oligosaccharyltansferase (OTase) PglB, responsible for N-linked protein glycosylation together with a suitable acceptor protein (AcrA) in Yersinia enterocolitica O9 cells. MS analysis of the acceptor protein demonstrated the transfer of a polymer of N-formylperosamine to AcrA in vivo. Because Y. enterocolitica O9 and Brucella abortus share an identical O polysaccharide structure, we explored the application of the resulting glycoprotein in vaccinology and diagnostics of brucellosis, one of the most common zoonotic diseases with over half a million new cases annually. Injection of the glycoprotein into mice generated an IgG response that recognized the O antigen of Brucella, although this response was not protective against a challenge with a virulent B. abortus strain. The recombinant glycoprotein coated onto magnetic beads was efficient in differentiating between naïve and infected bovine sera.
Conclusion: Bacterial engineered glycoproteins show promising applications for the development on an array of diagnostics and immunoprotective opportunities in the future.
Figures






Similar articles
-
Structural insights from random mutagenesis of Campylobacter jejuni oligosaccharyltransferase PglB.BMC Biotechnol. 2012 Sep 24;12:67. doi: 10.1186/1472-6750-12-67. BMC Biotechnol. 2012. PMID: 23006740 Free PMC article.
-
Increased efficiency of Campylobacter jejuni N-oligosaccharyltransferase PglB by structure-guided engineering.Open Biol. 2015 Apr;5(4):140227. doi: 10.1098/rsob.140227. Open Biol. 2015. PMID: 25833378 Free PMC article.
-
Engineering, conjugation, and immunogenicity assessment of Escherichia coli O121 O antigen for its potential use as a typhoid vaccine component.Glycoconj J. 2013 Jul;30(5):511-22. doi: 10.1007/s10719-012-9451-9. Epub 2012 Oct 6. Glycoconj J. 2013. PMID: 23053636
-
Hijacking bacterial glycosylation for the production of glycoconjugates, from vaccines to humanised glycoproteins.J Pharm Pharmacol. 2015 Mar;67(3):338-50. doi: 10.1111/jphp.12321. Epub 2014 Sep 22. J Pharm Pharmacol. 2015. PMID: 25244672 Free PMC article. Review.
-
Understanding protein glycosylation pathways in bacteria.Future Microbiol. 2017 Jan;12:59-72. doi: 10.2217/fmb-2016-0166. Epub 2016 Sep 30. Future Microbiol. 2017. PMID: 27689684 Review.
Cited by
-
Genetic and process engineering strategies for enhanced recombinant N-glycoprotein production in bacteria.Microb Cell Fact. 2021 Oct 14;20(1):198. doi: 10.1186/s12934-021-01689-x. Microb Cell Fact. 2021. PMID: 34649588 Free PMC article.
-
A Bacterial Glycoengineered Antigen for Improved Serodiagnosis of Porcine Brucellosis.J Clin Microbiol. 2016 Jun;54(6):1448-1455. doi: 10.1128/JCM.00151-16. Epub 2016 Mar 16. J Clin Microbiol. 2016. PMID: 26984975 Free PMC article.
-
Exploitation of bacterial N-linked glycosylation to develop a novel recombinant glycoconjugate vaccine against Francisella tularensis.Open Biol. 2013 May 22;3(5):130002. doi: 10.1098/rsob.130002. Open Biol. 2013. PMID: 23697804 Free PMC article.
-
A General Protein O-Glycosylation Gene Cluster Encodes the Species-Specific Glycan of the Oral Pathogen Tannerella forsythia: O-Glycan Biosynthesis and Immunological Implications.Front Microbiol. 2018 Aug 28;9:2008. doi: 10.3389/fmicb.2018.02008. eCollection 2018. Front Microbiol. 2018. PMID: 30210478 Free PMC article.
-
Application of an O-Linked Glycosylation System in Yersinia enterocolitica Serotype O:9 to Generate a New Candidate Vaccine against Brucella abortus.Microorganisms. 2020 Mar 20;8(3):436. doi: 10.3390/microorganisms8030436. Microorganisms. 2020. PMID: 32244903 Free PMC article.
References
-
- Fugier E, Pappas G, Gorvel JP. Virulence factors in brucellosis: implications for aetiopathogenesis and treatment. Expert Rev Mol Med. 2007;9(35):1–10. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources